← Evidence map

ArticleCommunications medicine2026

Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk.

Yu Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42218280